Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis. Wiebenga OT, Klauser AM, Schoonheim MM, Nagtegaal GJA, Steenwijk MD, van Rossum J, Polman CH, Barkhof F, Pouwels PJW, Geurts JJG AJNR Am J Neuroradiol. 2015 Mar 5. PMID: 25742985. Abstract CommentRecommendBookmarkWatch